Ascendis Pharma A/S (ASND) vs BioNTech SE Sponsored ADR (BNTX)
- Ascendis Pharma A/S ASND 255.84 +0.94%
- BioNTech SE Sponsored ADR BNTX 86.98 +1.30%
Ascendis Pharma A/S and BioNTech SE Sponsored ADR are both Biotechnology companies. BioNTech SE Sponsored ADR is the larger, with a market value of $21.6B against $16.6B — 1.3× the size. BioNTech SE Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Ascendis Pharma A/S trades at 18.3×. Ascendis Pharma A/S grew revenue faster over the last twelve months: 126.0% against −22.7%. Ascendis Pharma A/S has the higher net margin (71.2% vs −63.8%) and the higher return on invested capital (15.1% vs −34.3%). Across the 18 metrics below, Ascendis Pharma A/S leads on 13 and BioNTech SE Sponsored ADR on 5.
Valuation
Profitability
| Metric | ASND | BNTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.26% | 74.59% | 65.16% |
| Operating margin | 24.84% | (78.99%) | 0.00% |
| Net margin | 71.20% | (63.77%) | 0.00% |
| Free cash flow margin | 31.97% | (19.21%) | 0.00% |
| Return on equity | 118.44% | (8.29%) | (50.12%) |
| Return on assets | 44.34% | (7.22%) | (45.60%) |
| Return on invested capital | 15.07% | (34.28%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack